[SG Region] S4 W2 Spotlight

PaperTradingOfficial joined discussion · Oct 22, 2021 17:43

Dear moomooers

Welcome back to the fourth season of the U.S. Stock Paper Trading Competition held by moomoo!As 2021 is coming to an end, the current fourth season would be the final season of the competition for this year.Take your chance to earn our grand prize for the last season.

Moomoo would like to continuously provide you with the opportunity to demonstrate your investment technique, strategy, and portfolio management in our monthly competition. You are more than welcome to communicate your investment experience during the competition with others and ever further in future investment on moomoo.

With given virtual cash, traders can build out the portfolio they always dreamed of, all experience levels investors were welcomed and top performers will be rewarded final prizes.Now let’s take a look at how did our leading participants perform in the previous week.

Market Recap

Stocks began the previous week with losses, but turned higher after companies ranging from banks to insurers delivered robust results for the latest quarter.

Economic data also helped reassure investors about the growth outlook. Data Friday showed retail sales unexpectedly rose in September, despite economists' worries about the Delta variant of Covid-19 and the end of enhanced unemployment benefits.

The $S&P 500 Index (.SPX.US)$ added 33.11 points, or 0.7%, to 4471.37 and jumped 1.8% for the week, posting its best weekly performance since July. The $Dow Jones Industrial Average (.DJI.US)$ gained 382.20 points, or 1.1%, to 35294.76 and advanced 1.6% for the week, delivering its biggest weekly gain since June.

The technology-focused $Nasdaq Composite Index (.IXIC.US)$ ticked up 73.91 points, or 0.5%, to 14897.34 and climbed 2.2% for the week.

Stock of The Week

$ChemoCentryx (CCXI.US)$ was the most trending stock among our participants during the previous week. Share of $ChemoCentryx (CCXI.US)$ was trading 56% higher after receiving FDA approval for one of the most important drugs in its pipeline- Vasculitis Treatment. Vasculitis is a rare autoimmune disorder. Those who suffer from it experience thickening of the arteries.

Performance Tracking

NO.1

User 102869587 has achieved first place in the competition this week, with a total P/L of 52.9%. He has successfully seized a decent return from $ChemoCentryx (CCXI.US)$ by purchasing over 4000 shares of the previously mentioned medical company, as the stock price almost doubled. He also invested heavily in crypto-related companies as the legendary cryptocurrency bitcoin topped $68,000.

NO.2

User 102721332 came in second with a total return of 50.71%. He obtained the outstanding return mainly with two stocks: $ChemoCentryx (CCXI.US)$ and $Gitlab (GTLB.US)$. As the strongest competitor of Github, Gitlab shares surged in their trading debut, closing up 35% higher than the DevOps software company's initial public offering price. This User has made several successful trades on both of the stocks by buying the dip and selling higher.

NO.3

User dkhang achieved third place in the second week with a 47.16% of total P/L. He obtained most of the return by investing over 4000 shares of CCXI and received over 100% return from this single stock. Despite he has started the season strong, he still has not found the next lucky stock. His following trades are diminishing his portfolio return. let's wish him good luck.

NO.4

User Terence obtained 41.42% so far in the season with over 200 trades. He has obtained his return mainly by day-trading stocks with strong momentum and holding medical stocks with strong fundamental investment value. His portfolio shows his profession in the healthcare sector, as he invested in several medical stocks with promising expectations, including Ocugen, ChemoCentryx, MannKind and Allogene Therapeutics.

NO.5

User steavyG has achieved fifth place in the competition this week with a total P/L of 41.22%. This user has obtained a decent return from ChemoCentryx as well. This user prefers medical companies and energy companies. Both natural gas and crude are spiking up as the winter approaches. Bank of America Global Research even believes it could bring forward its $100 per barrel oil price target to the next several months. These energy stocks could help steavyG win the competition in the next few weeks.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

169K Views

Comment

Lay Pheng : Wow

Report
Reply

Cancel Reply

PaperTradingOfficial

Moomoo Official Account

Everything you want to know about Paper Trading💙

21KFollowers

114Following

24KVisitors